Freestone Grove Partners’s CME Group CME Stock Holding History
Bought
Maintained
Sold
Other funds holding CME
Freestone Grove Partners's CME Position: Q2 2026 in Review
Freestone Grove Partners increased its CME Group (CME) stake by 190% in Q2 2026, buying an estimated $29.6M and bringing the position to 162,979 shares worth $36M. The position accounts for 0.23% of the portfolio, ranked #133.
Freestone Grove Partners first reported a position in CME in Q4 2024 and has held it in 5 quarters since. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Freestone Grove Partners held 162,979 shares of CME Group worth $36M as of Q2 2026.
- Freestone Grove Partners bought 106,826 CME Group shares in Q2 2026, an estimated $29.6M.
- CME Group made up 0.23% of Freestone Grove Partners's portfolio in Q2 2026, its #133 holding.
- Freestone Grove Partners first reported a position in CME Group in Q4 2024 and has held it in 5 quarters since.
- 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.